A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma (EVERMORE)

Share this content:
A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma (EVERMORE)

Sponsor and Collaborators
Novartis Pharmaceuticals

Contact
Novartis Pharmaceuticals
+1 800-340-6843

Study Director
Novartis Pharmaceuticals

ClinicalTrials.gov Identifier
NCT01206764
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters